{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:07:50Z","timestamp":1791864470887,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1147","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan","award":["VGHKS 104-129, 104-058, 104-133, 103-121, 103-124,"],"award-info":[{"award-number":["VGHKS 104-129, 104-058, 104-133, 103-121, 103-124,"]}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST103-2314-B-075B-00"],"award-info":[{"award-number":["MOST103-2314-B-075B-00"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan","award":["VGHKS 104-129, 104-058, 104-133, 103-121, 103-124,"],"award-info":[{"award-number":["VGHKS 104-129, 104-058, 104-133, 103-121, 103-124,"]}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST103-2314-B-075B-00"],"award-info":[{"award-number":["MOST103-2314-B-075B-00"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Use of statin has been associated with reduced risk of cardiovascular diseases events and mortality. However, in patients with end-stage renal disease (ESRD), the protective effects of statin are controversial. To evaluate the impact of chronic statin use on clinical outcomes of patients with acute myocardial infarction (AMI) with ESRD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled 8056 patients with ESRD who were initially diagnosed and admitted for first AMI from Taiwan\u2019s National Health Insurance Research Database. Of which, 2134 patients underwent statin therapy. We randomly selected and use age, sex, hypertension, diabetes mellitus (DM), peripheral vascular diseases (PVD), heart failure (HF), cerebrovascular accidents (CVA), chronic obstructive pulmonary disease, matched with the study group as controls (non-stain user). We compared the effects of statin use in term of all-cause death among patients with AMI with ESRD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Statin use resulted in a significantly higher survival rate in patients ith AMI with ESRD compared with non-statin users. After adjusted the comorbidities the male patients and patients with DM, PVD, HF and CVA had lower long-term survival rate (all p&amp;lt;0.001). Patients who underwent percutaneous coronary intervention (p&amp;lt;0.001), ACE inhibitors\/angiotensin II receptor blockers (p&amp;lt;0.001), \u03b2 receptor blockers (p&amp;lt;0.001) and statin therapy (p=0.007) had better long-term survival rate. Patients with AMI with ESRD on statin therapy exhibited a significantly lower risk of mortality compared with non-statin users (p&amp;lt;0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among patients with ESRD with AMI, statin therapy was associated with reduced all-cause mortality.<\/jats:p><\/jats:sec>","DOI":"10.1136\/postgradmedj-2019-137292","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T18:22:21Z","timestamp":1610734941000},"page":"299-305","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of statin on long-term outcome among patients with end-stage renal disease with acute myocardial infarction (AMI): a nationwide case\u2013control study"],"prefix":"10.1093","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9254-7753","authenticated-orcid":false,"given":"Feng-You","family":"Kuo","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Kaohsiung Veterans General Hospital , Kaohsiung City, Taiwan"},{"name":"Department of Food Science, National Pingtung University of Science and Technology , Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chun","family":"Huang","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ling","family":"Tang","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hung","family":"Chiang","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chin","family":"Lin","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Jung","family":"Chuang","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shue-Ren","family":"Wann","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yuan","family":"Mar","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital , Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juei-Tang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Food Science, National Pingtung University of Science and Technology , Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Food Science, National Pingtung University of Science and Technology , Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2023041707101440200_","first-page":"281","article-title":"Cardiovascular disease in patients with chronic kidney disease. A clinical review","volume":"59","author":"Kaisar","year":"2007","journal-title":"Minerva Urol Nefrol"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000046979","article-title":"Epidemiology of vascular disease in renal failure","volume":"20","author":"Ikizler","year":"2002","journal-title":"Blood Purif"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/ndt\/gfn613","article-title":"Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease","volume":"24","author":"Covic","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/heartjnl-2012-302818","article-title":"Arterial disease in chronic kidney disease","volume":"99","author":"Moody","year":"2013","journal-title":"Heart"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2215\/CJN.01260210","article-title":"Effect of kidney disease on acute coronary syndrome","volume":"5","author":"Rodrigues","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2215\/CJN.00150106","article-title":"Kidney function and use of recommended medications after myocardial infarction in elderly patients","volume":"1","author":"Winkelmayer","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.ajkd.2005.10.009","article-title":"Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction","volume":"47","author":"Winkelmayer","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2010.11.035","article-title":"Effect of long term, non cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats","volume":"654","author":"Cumao\u011flu","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.hlc.2015.10.012","article-title":"Effects of combination of ezetimibe and rosuvastatin on coronary artery plaque in patients with coronary heart disease","volume":"25","author":"Wang","year":"2016","journal-title":"Heart Lung Circ"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4103\/2230-8210.163106","article-title":"Pleiotropic effects of statins","volume":"19","author":"Kavalipati","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1371\/journal.pmed.0030333","article-title":"Statins in the treatment of chronic heart failure: a systematic review","volume":"3","author":"van der Harst","year":"2006","journal-title":"PLoS Med"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"e1644","DOI":"10.1097\/MD.0000000000001644","article-title":"Statin use reduces prostate cancer all-cause mortality: a nationwide population-based cohort study","volume":"94","author":"Sun","year":"2015","journal-title":"Medicine"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2013.03.007","article-title":"Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants","volume":"72","author":"Barylski","year":"2013","journal-title":"Pharmacol Res"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","article-title":"Validation of acute myocardial infarction cases in the National health insurance research database in Taiwan","volume":"24","author":"Cheng","year":"2014","journal-title":"J Epidemiol"},{"key":"2023041707101440200_","first-page":"387","article-title":"Five-Year outcomes after acute myocardial infarction in patients with and without diabetes mellitus in Taiwan, 1996-2005","volume":"29","author":"Chiang","year":"2013","journal-title":"Zhonghua Minguo xin zang xue hui za zhi = Acta Cardiologica Sinica"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"984","DOI":"10.5114\/aoms.2011.26610","article-title":"Improving the implementation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The imperative renal analysis","volume":"7","author":"Athyros","year":"2011","journal-title":"Arch Med Sci"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/j.ajkd.2008.11.025","article-title":"Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD","volume":"53","author":"Koren","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2023041707101440200_","first-page":"CD007784","article-title":"Hmg CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis","author":"Navaneethan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.39472.580984.AE","article-title":"Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials","volume":"336","author":"Strippoli","year":"2008","journal-title":"BMJ"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1523-1755.2002.00109.x","article-title":"Hmg-Coa reductase inhibitors are associated with reduced mortality in ESRD patients","volume":"61","author":"Seliger","year":"2002","journal-title":"Kidney Int"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"e006886","DOI":"10.1136\/bmjopen-2014-006886","article-title":"High-Intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"5","author":"Yan","year":"2015","journal-title":"BMJ Open"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"e0132970","DOI":"10.1371\/journal.pone.0132970","article-title":"Effects of statins on renal outcome in chronic kidney disease patients: a systematic review and meta-analysis","volume":"10","author":"Sanguankeo","year":"2015","journal-title":"PLoS One"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10157-013-0889-2","article-title":"Statins in chronic kidney disease: what do meta-analyses tell us?","volume":"18","author":"Upadhyay","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/eht065","article-title":"Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Hou","year":"2013","journal-title":"Eur Heart J"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.RES.62.2.367","article-title":"Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5\/6 nephrectomy model of chronic renal failure","volume":"62","author":"Kasiske","year":"1988","journal-title":"Circ Res"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2215\/CJN.09091010","article-title":"The efficacy and safety of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in chronic kidney disease, dialysis, and transplant patients","volume":"6","author":"Olyaei","year":"2011","journal-title":"CJASN"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ki.2015.228","article-title":"Comorbidity as a driver of adverse outcomes in people with chronic kidney disease","volume":"88","author":"Tonelli","year":"2015","journal-title":"Kidney Int"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"III-39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"II-18","DOI":"10.1161\/01.CIR.0000129505.34151.23","article-title":"Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?","volume":"109","author":"Sch\u00f6nbeck","year":"2004","journal-title":"Circulation"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2362.2002.01086.x","article-title":"Time-Dependent effect of statins on platelet function in hypercholesterolaemia","volume":"32","author":"Puccetti","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"2023041707101440200_","doi-asserted-by":"crossref","first-page":"II-34","DOI":"10.1161\/01.CIR.0000129503.62747.03","article-title":"Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress","volume":"109","author":"Mason","year":"2004","journal-title":"Circulation"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/97\/1147\/299\/49933019\/postgradmedj-97-299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/97\/1147\/299\/49933019\/postgradmedj-97-299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:47:34Z","timestamp":1697575654000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/97\/1147\/299\/6969675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":35,"journal-issue":{"issue":"1147","published-online":{"date-parts":[[2021,1,15]]},"published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2019-137292","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2021,1,15]]}}}